tradingkey.logo

IM Cannabis Corp

IMCC
查看詳細走勢圖
1.280USD
-0.020-1.54%
收盤 02/02, 16:00美東報價延遲15分鐘
6.72M總市值
虧損本益比TTM

IM Cannabis Corp

1.280
-0.020-1.54%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.54%

5天

-6.57%

1月

-14.09%

6月

-49.41%

今年開始到現在

-7.91%

1年

-41.01%

查看詳細走勢圖

TradingKey IM Cannabis Corp股票評分

單位: USD 更新時間: 2026-02-02

操作建議

IM Cannabis Corp當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在食品與藥房零售行業排名28/30位。機構持股佔比非常高,近一月多位分析師給出公司評級為。最高目標價為0.00。近一個月,市場表現較差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

IM Cannabis Corp評分

相關信息

行業排名
28 / 30
全市場排名
464 / 4529
所屬行業
食品與藥房零售

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

IM Cannabis Corp亮點

亮點風險
IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
業績增長期
公司處於發展階段,最新年度總收入37.56M美元
估值低估
公司最新PE估值-1.48,處於3年歷史低位
機構加倉
最新機構持股964.07K股,環比增加38.56%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉11.43K股

分析師目標

基於 0 分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

IM Cannabis Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

IM Cannabis Corp簡介

IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
公司代碼IMCC
公司IM Cannabis Corp
CEOFisher (Eyal)
網址https://imcannabis.com/
KeyAI